Abstract

A novel recyclable surface-enhanced Raman scattering (SERS)-based immunoassay was demonstrated and exhibited extremely high sensitivity toward prostate specific antigen (PSA). The immunoassay, which possessed a sandwich structure, was constructed of multifunctional Fe3O4@TiO2@Au nanocomposites as immune probe and Ag-coated sandpaper as immune substrate. First, by adjusting the density of outside Au seeds on Fe3O4@TiO2 core-shell nanoparticles (NPs), the structure-dependent SERS and photocatalytic performance of the samples was explored by monitoring and degradating 4-mercaptobenzonic acid (4MBA). Afterwards, the SERS enhancement capability of Ag-coated sandpaper with different meshes was investigated, and a limit of detection (LOD), as low as 0.014 mM, was achieved by utilizing the substrate. Subsequently, the recyclable feasibility of PSA detection was approved by zeta potential measurement, absorption spectra, and SEM images and, particularly, more than 80% of SERS intensity still existed after even six cycles of immunoassay. The ultralow LOD of the recyclable immunoassay was finally calculated to be 1.871 pg/mL. Therefore, the recyclable SERS-based immunoassay exhibits good application prospects for diagnosis of cancer in clinical measurements.

Highlights

  • Prostate cancer has become the second most common non-skin malignancies in men worldwide [1,2]

  • The recyclable detection of prostate specific antigen (PSA) was successfully achieved based on only one batch of the sandwich immune structure, which is combined with multifunctional Fe3 O4 @TiO2 @Au nanocomposites and Ag-coated sandpaper

  • The structure-dependent Surface-enhanced Raman scattering (SERS) and photocatalytic performance of nanocomposites was systematically investigated by adjusting the density of outside Au seeds on Fe3 O4 @TiO2 NPs, and the optimum performance was found in the samples prepared by employing 100 mL Au seed solution

Read more

Summary

Introduction

Prostate cancer has become the second most common non-skin malignancies in men worldwide [1,2]. To impede this pressing trend, it is essential to realize the early diagnosis and therapeutics of prostate cancer for which prostate specific antigen (PSA) has been the most extensively applied directional tumor marker [3]. Surface-enhanced Raman scattering (SERS) technique has attracted wide interest as a method extensively utilized in the field of labeled immunoassay for monitoring specific cancer antigens, mainly due to a number of advantages such as good spectral selectivity, no self-quenching and photobleaching, higher sensitivity, and multicomponent detection ability [4,5,6,7,8,9,10]. Owing to Biosensors 2020, 10, 25; doi:10.3390/bios10030025 www.mdpi.com/journal/biosensors

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call